JP2004506722A5 - - Google Patents

Download PDF

Info

Publication number
JP2004506722A5
JP2004506722A5 JP2002521433A JP2002521433A JP2004506722A5 JP 2004506722 A5 JP2004506722 A5 JP 2004506722A5 JP 2002521433 A JP2002521433 A JP 2002521433A JP 2002521433 A JP2002521433 A JP 2002521433A JP 2004506722 A5 JP2004506722 A5 JP 2004506722A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
ethoxy
oxazol
propionic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002521433A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004506722A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/022617 external-priority patent/WO2002016332A1/en
Publication of JP2004506722A publication Critical patent/JP2004506722A/ja
Publication of JP2004506722A5 publication Critical patent/JP2004506722A5/ja
Withdrawn legal-status Critical Current

Links

JP2002521433A 2000-08-23 2001-08-23 ペルオキシソーム増殖因子活性化受容体の調節方法 Withdrawn JP2004506722A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22745600P 2000-08-23 2000-08-23
PCT/US2001/022617 WO2002016332A1 (en) 2000-08-23 2001-08-23 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists

Publications (2)

Publication Number Publication Date
JP2004506722A JP2004506722A (ja) 2004-03-04
JP2004506722A5 true JP2004506722A5 (enExample) 2008-10-09

Family

ID=22853183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002521433A Withdrawn JP2004506722A (ja) 2000-08-23 2001-08-23 ペルオキシソーム増殖因子活性化受容体の調節方法

Country Status (10)

Country Link
US (1) US7176224B2 (enExample)
EP (1) EP1313717B1 (enExample)
JP (1) JP2004506722A (enExample)
AT (1) ATE375985T1 (enExample)
AU (1) AU2001284660A1 (enExample)
CA (1) CA2418134A1 (enExample)
DE (1) DE60131001T2 (enExample)
ES (1) ES2295200T3 (enExample)
MX (1) MXPA03001610A (enExample)
WO (1) WO2002016332A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2420178A1 (en) * 2000-08-23 2002-03-07 Eli Lilly And Company Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
DK1313716T3 (da) * 2000-08-23 2007-08-27 Lilly Co Eli Oxazolyl-arylpropionsyrederivater og anvendelse deraf som PPAR-agonister
DE60216094T2 (de) * 2001-06-07 2007-06-06 Eli Lilly And Co., Indianapolis Modulatoren der peroxisom-proliferator-aktivierten rezeptoren (ppar)
CN1543451A (zh) * 2001-06-07 2004-11-03 过氧化物酶体增生剂激活的受体的调节剂
MXPA04003398A (es) * 2001-10-12 2004-11-22 Nippon Chemiphar Co Activador para el receptor o activado con el proliferador de peroxisoma.
US20050080115A1 (en) * 2002-10-28 2005-04-14 Lone Jeppesen Novel compounds, their preparation and use
CA2503117C (en) 2002-11-08 2010-12-21 F. Hoffmann-La Roche Ag Substituted 4-alkoxyoxazol derivatives as ppar agonists
US7192970B2 (en) * 2002-11-26 2007-03-20 Chipscreen Biosciences, Ltd. Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
CN1751037A (zh) 2003-02-14 2006-03-22 伊莱利利公司 作为ppar调节剂的磺酰胺衍生物
DE102004060227B3 (de) 2004-12-15 2006-07-20 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Oxazolen durch Kondensation von aromatischen Aldehyden mit α-Ketoximen zu N-Oxiden und nachfolgende Reaktion mit aktivierten Säurederivaten
US20090054435A1 (en) * 2005-07-29 2009-02-26 Hiroshi Imoto Phenoxyalkanoic Acid Compound
BR112012002311A2 (pt) * 2009-08-05 2016-05-31 Daiichi Sankyo Co Ltd composto, composição farmacêutica, e, uso do composto.
SG189320A1 (en) * 2010-10-14 2013-05-31 Daiichi Sankyo Co Ltd Acylbenzene derivative

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
US5232945A (en) 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
US5902726A (en) 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
JP2002503202A (ja) 1996-02-02 2002-01-29 メルク エンド カンパニー インコーポレーテッド 抗糖尿病薬
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
RU2174121C2 (ru) * 1996-08-19 2001-09-27 Джапан Тобакко Инк. Производные пропионовой кислоты и фармацевтическая композиция на их основе
DE69941777D1 (de) * 1998-03-10 2010-01-21 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
WO2001016120A1 (en) * 1999-08-27 2001-03-08 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
JP4316787B2 (ja) 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、
DK1313716T3 (da) 2000-08-23 2007-08-27 Lilly Co Eli Oxazolyl-arylpropionsyrederivater og anvendelse deraf som PPAR-agonister
CA2420178A1 (en) 2000-08-23 2002-03-07 Eli Lilly And Company Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists

Similar Documents

Publication Publication Date Title
JP2009519965A5 (enExample)
JP2004534824A5 (enExample)
JP2013519680A5 (enExample)
JP2004529174A5 (enExample)
JP2007511485A5 (enExample)
JP2004506721A5 (enExample)
JP2004534035A5 (enExample)
JP2021511360A5 (enExample)
HRP20160450T1 (hr) Novi inhibitori reduktaze s-nitrozoglutationa
US20140039009A1 (en) Compounds for inflammation and immune-related uses
JP2005528348A5 (enExample)
JP2007505916A5 (enExample)
JP2019517455A5 (enExample)
JP2014510132A5 (enExample)
JP2007520471A5 (enExample)
JP2010513397A5 (enExample)
JP2009520769A5 (enExample)
CA2565813A1 (en) Substituted methyl aryl or heteroaryl amide compounds
JP2008507532A5 (enExample)
JP2005539088A5 (enExample)
JP2003528918A5 (enExample)
JP2008526866A5 (enExample)
JP2005526081A5 (ja) 代謝型グルタメート受容体−5の二アリール置換テトラゾールモジュレータ
JP2009540009A5 (enExample)
JP2007523181A5 (enExample)